STAT

NOVEMBER 24, 2023

UnitedHealth Group’s Optum division is already the largest employer of physicians in the United States, but allegations in a new lawsuit suggest Optum is hungry for more. Emanate Health, a nonprofit group of hospitals and physicians in California, filed a federal lawsuit Monday, alleging Optum pushed it to agree not to compete for primary care physicians, a violation of antitrust law.

Hospitals 362

Hospitals 362

European Pharmaceutical Review

NOVEMBER 24, 2023

Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment. Results from the trial were published in the New England Journal of Medicine.

Hospitals 116

Hospitals Dosage 116

STAT

NOVEMBER 24, 2023

Reports this week that China is experiencing a surge in respiratory infections in young children triggered flashbacks of the start of the Covid-19 pandemic among infectious disease watchers. But a rapidly organized meeting Thursday between the World Health Organization and health officials in China assuaged much of that concern. The evidence presented to the WHO team pointed to what’s sometimes called an immunity gap that was created by the pandemic.

Immunization 363

Immunization Immunity 363

Pharmafile

NOVEMBER 24, 2023

Alladapt Immunotherapeutics has announced that ADP101 has received Fast Track Designation from the US Food and Drug Administration (FDA) as a treatment for one or more food allergens. ADP101 is currently the most advanced multi-food oral immunotherapy (mOIT) candidate in development, and there are currently no FDA-approved OIT treatments for multi-food allergy to foods other […] The post Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment appea

105

105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 24, 2023

I had only lived in Kibera for 15 minutes when I saw a police officer and was arrested. But it would be years before I saw a real doctor. In 2001, at the age of 13, I had come to Kenya’s largest informal settlement on the outskirts of Nairobi with my sister. When we arrived at 3 a.m., we dutifully called my uncle from a phone booth to pick us up.

296

296

Pharma Times

NOVEMBER 24, 2023

Around 3,200 new cases of cervical cancer are diagnosed in the UK every year - News - PharmaTimes

132

132

European Pharmaceutical Review

NOVEMBER 24, 2023

Novo Nordisk is investing over €2.1 billion (16 billion Danish kroner) to expand its production site in Chartres, France, supporting manufacture of its products for serious chronic diseases. Novo Nordisk’s multi-billion facility expansion This financial commitment will greatly strengthen manufacturing capacity, more than doubling the site’s footprint.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Packaging 98

Pharma Times

NOVEMBER 24, 2023

The findings could benefit patients living with neurodegenerative conditions - News - PharmaTimes

124

124

European Pharmaceutical Review

NOVEMBER 24, 2023

The European Commission has granted a label expansion of the combination treatment KAFTRIO ® (ivacaftor/tezacaftor/elexacaftor) with ivacaftor, for children aged two to five years old with cystic fibrosis. The treatment from Vertex Pharmaceuticals is indicated for individuals who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator ( CYSTIC FIBROSISTR ) gene.

Labelling 98

Labelling 98

The Pharmacist

NOVEMBER 24, 2023

Service specifications and patient group directions (PGDs) for the extended Community Pharmacy Contraceptive Service and Hypertension Case Finding Service have been published on the NHS England (NHSE) website. Under new rules, from 1 December community pharmacies will be able to initiate oral contraception, and all suitably trained members of the pharmacy team will be able […] The post NHS unveils specifications and PGDs for new pharmacy services appeared first on The Pharmacist.

Community Pharmacies 93

Community Pharmacies 93

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Express Pharma

NOVEMBER 24, 2023

The 16 th edition of CPHI & PMEC India Expo, organised by Informa Markets in India, will be held from November 28-30, 2023, at the India Expo Centre in Greater Noida, Delhi. CPHI & PMEC India, along with its ancillary programmes, spotlights technological strides pivotal in propelling India’s pharma machinery, technology, and ingredients sectors.

Packaging 96

Packaging Vaccines Pharmaceutical Manufacturing Hospitals 96

Pharmaceutical Technology

NOVEMBER 24, 2023

Bayer announced the launch of a Berlin, Germany-based manufacturing facility to meet future demands from the US, China and Europe.

105

105

Outsourcing Pharma

NOVEMBER 24, 2023

Calliditas Therapeutics AB announced today (November 24) that its partner Everest Medicines has revealed that China's National Medical Products Administration (NMPA) has approved Nefecon.

80

80

pharmaphorum

NOVEMBER 24, 2023

International Health Partners' Christmas campaign: Working with pharma for patients worldwide Nicole.

106

106

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Outsourcing Pharma

NOVEMBER 24, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).

Pharmaceutical Companies 76

Pharmaceutical Companies Pharmaceutical Companies 76

PharmaTech

NOVEMBER 24, 2023

The largest biotech hub is set to be built in Lithuania by Northway Group.

105

105

pharmaphorum

NOVEMBER 24, 2023

How to optimise commercial-scale ATMP manufacturing through automation Mike.

113

113

Drug Patent Watch

NOVEMBER 24, 2023

This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Business Review

NOVEMBER 24, 2023

A therapy platform developed by T3 Pharma using engineered Yersinia enterocolitica bacteria, delivers immune-modulating proteins to cancer cells and tumour micro-environments, sparing healthy tissues. The bacteria can be loaded with several selective immune-modulatory proteins, enabling the design of immuno-oncology combination therapies in one single agent.

Immunization 59

Immunization Immunity 59

Drug Patent Watch

NOVEMBER 24, 2023

Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twenty-six patents protecting… The post New patent for Abbvie drug RINVOQ appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmafile

NOVEMBER 24, 2023

Freeline Therapeutics has announced that it has entered into a definitive agreement with newly established portfolio company Syncona, in which Syncona will acquire Freeline in an all-cash transaction. Syncona will pay $6.50 per share, or an approximate total of $28.3m. The acquisition is expected to close in the first quarter of 2024, although it is […] The post Syncona to acquire Freeline Therapeutics for $28.3m appeared first on Pharmafile.

59

59

Drug Patent Watch

NOVEMBER 24, 2023

Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are… The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

World Pharma News

NOVEMBER 24, 2023

Lidocaine - often used as numbing agent for outpatient medical procedures - activates certain bitter taste receptors through two unique mechanisms that result in cancer cell death, according to researchers from the Perelman School of Medicine at the University of Pennsylvania. Their findings, published in Cell Reports, pave the way for a clinical trial to test the addition of lidocaine to the standard of care therapy for patients with head and neck cancers.

67

67

Outsourcing Pharma

NOVEMBER 24, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

NOVEMBER 24, 2023

After launching Bevacizumab for the treatment of metastatic colorectal cancer, Pune-based Enzene Biosciences has now followed it up with the launch of Ranibizumab, a biosimilar to innovator product Lucentis that is sold under the brand name Accentrix in India. A recombinant Fab that is used as a therapy for neovascular age-related macular degeneration (AMD), the Ranibizumab biosimilar is the company’s seventh biosimilar and could significantly lower treatment costs for thousands of Indian patien

Biosimilars 52

Biosimilars 52

The Pharmacist

NOVEMBER 24, 2023

More support and education are needed for perimenopausal women who are experiencing menstrual changes, researchers have said. A new study has shown that as periods may become unpredictable, heavier and more painful and the menopause gets closer, women say they need both practical and emotional support in both their working and personal lives. The findings […] The post Women need more support around perimenopause menstruation changes, study shows appeared first on The Pharmacist.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma and Life Sciences Blog

NOVEMBER 24, 2023

Procurement Leadership Insights: A Latin America Perspective annmarie@AZglo… Fri, 11/24/2023 - 15:22 Latin America finds itself reshaped by the global pandemic and its businesses are recalibrating their steps to find the elusive competitive edge. Chief procurement officers (CPOs) have emerged as the navigators in this transition. Their perspectives, strategies and decisions can chart the course for businesses across the region.

52

52

The Pharmacist

NOVEMBER 24, 2023

Independent pharmacies are increasingly closing their doors because of ongoing funding pressures, leaving patients unsure where to turn to, an influential committee of MPs has been told. Vice chair of the National Pharmacy Association Jay Badenhorst told the Health and Social Care Committee earlier this week that ‘for a lot of independent businesses, there is […] The post Patients left ‘unsure where to turn to’ amid increasing pharmacy closures appeared first on The Pharmacist.

Independent Pharmacies 56

Independent Pharmacies 56

Pharmaceutical Technology

NOVEMBER 24, 2023

Vertex Pharmaceuticals has obtained approval from EC) for the label expansion of Kaftrio plus ivacaftor to treat children with CF.

Labelling 59

Labelling 59

Pharmacy Times

NOVEMBER 24, 2023

For pharmacists and pharmacy technicians, who work diligently to ensure our health and well-being, choosing the perfect holiday gift can be a thoughtful way to express gratitude and brighten their season.

Pharmacy Technician 59

Pharmacy Technician 59

Pharmaceutical Technology

NOVEMBER 24, 2023

The Sosei Heptares oral IBD drug was first licensed to GSK in 2020 and is currently in Phase I clinical development.

59

59